Cargando…
Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252413/ http://dx.doi.org/10.1016/S0168-8278(22)01883-9 |
| _version_ | 1784740259402088448 |
|---|---|
| author | Mendizabal, Manuel Ducasa, Nicolas Benencio, Paula Anders, Maria Margarita Cairo, Fernando Alter, Adriana Etcheves, Patricia Scarton, Giampaolo Biglione, Mirna Mauro, Ezequiel |
| author_facet | Mendizabal, Manuel Ducasa, Nicolas Benencio, Paula Anders, Maria Margarita Cairo, Fernando Alter, Adriana Etcheves, Patricia Scarton, Giampaolo Biglione, Mirna Mauro, Ezequiel |
| author_sort | Mendizabal, Manuel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9252413 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92524132022-07-05 Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients Mendizabal, Manuel Ducasa, Nicolas Benencio, Paula Anders, Maria Margarita Cairo, Fernando Alter, Adriana Etcheves, Patricia Scarton, Giampaolo Biglione, Mirna Mauro, Ezequiel J Hepatol POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252413/ http://dx.doi.org/10.1016/S0168-8278(22)01883-9 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects Mendizabal, Manuel Ducasa, Nicolas Benencio, Paula Anders, Maria Margarita Cairo, Fernando Alter, Adriana Etcheves, Patricia Scarton, Giampaolo Biglione, Mirna Mauro, Ezequiel Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title | Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title_full | Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title_fullStr | Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title_full_unstemmed | Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title_short | Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| title_sort | heterologous regimen viral-vector/mrna produces significantly higher sars-cov-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients |
| topic | POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252413/ http://dx.doi.org/10.1016/S0168-8278(22)01883-9 |
| work_keys_str_mv | AT mendizabalmanuel heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT ducasanicolas heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT benenciopaula heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT andersmariamargarita heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT cairofernando heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT alteradriana heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT etchevespatricia heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT scartongiampaolo heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT biglionemirna heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients AT mauroezequiel heterologousregimenviralvectormrnaproducessignificantlyhighersarscov2humoralresponsethanhomologousviralvectorandinactivatedvaccinesinlivertransplantrecipients |